Anglican: Obtain the registration certificate of Mesobamo injection.

date
31/07/2025
Anglicon announcement, the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Mepivacaine Injection. Mepivacaine Injection is mainly used for the treatment of acute musculoskeletal pain or discomfort symptoms, belonging to Chemical Drugs Class 3, with a specification of 10ml:1g. Obtaining the Drug Registration Certificate this time will further enrich the company's product pipeline. According to relevant national policies, obtaining the "Drug Registration Certificate" this time is considered equivalent to passing consistency evaluation. The specific sales situation may be affected by factors such as national policies, market environment changes, etc., and there is a high degree of uncertainty.